Keto Outperformed the Mediterranean Diet in a Major Metabolic Health Trial

The diet wars have a new scoreboard. In a clinical trial involving people with obesity, prediabetes, and fatty liver disease, a ketogenic diet outperformed both the Mediterranean diet and a low-fat diet on several key measures of metabolic health.

The trial matters because these are not obscure fad regimens competing for headlines; they are three of the most widely recommended eating patterns in medicine. The Mediterranean diet is the cardiologist’s favorite, low-fat eating has decades of official backing, and ketogenic diets have surged in popularity while remaining scientifically contested.

What the trial found

Participants following the ketogenic diet, which slashes carbohydrates and shifts the body into burning fat for fuel, showed stronger improvements in measures tied to metabolic syndrome: blood sugar control, triglycerides, and markers of fatty liver disease, the condition quietly spreading through populations alongside obesity.

Fatty liver disease is the standout detail. It now affects a huge share of adults in many countries and has few approved treatments, making dietary results with this kind of effect especially valuable.

Before you clean out the pantry

The caveats are real. Trials measure averages, not individuals; adherence is famously difficult with strict diets; and long-term effects of ketogenic eating are still debated, particularly for heart health. The Mediterranean diet retains a mountain of supporting evidence for longevity and cardiovascular outcomes.

The practical takeaway may be the least glamorous one: for people with obesity and metabolic disease, the best diet is increasingly the one matched to their condition and their life, and the evidence for personalizing that choice is getting stronger.

Featured image: avocado, via Wikimedia Commons. Source: ScienceDaily.